Immunodominance of an Antiviral Cytotoxic T Cell Response Is Shaped by the Kinetics of Viral Protein Expression

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 5415-5422

  Probst, Hans Christian ^a   Tschannen, Kathrin ^a   Gallimore, Awen ^b,d   Martinic, Marianne ^a   Basler, Michael ^c   Dumrese, Tilman ^a   Jones, Emma ^b   Van Den Broek, Maries F ^a,e  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; NUCLEOPROTEIN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNOSTIMULATION; KINETICS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

EID: 0242410976     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.5415     Document Type: Article

References (63)

1. Rammensee, H., K. Falk, and O. Rötschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213.
2. Momburg, F., and G. Hämmerling. 1998. Generation and TAP-mediated transport of peptides for MHC class I molecules. Adv. Immunol. 68:191.
3. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I restricted CTL in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211.
4. Groettrup, M., A. Soza, U. Kuckelkorn, and P. Kloetzel. 1996. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 17:429.
5. Zinkernagel, R., and P. Doherty. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction specificity, function and responsiveness. Adv. Immunol. 27:52.
6. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K. Olsen, E. Podack, R. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
7. Riddell, S., K. Watanabe, J. Goodrich, C. Li, M. Agha, and P. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science 257:238.
8. Rickinson, A., and B. Moss. 1997. Human CTL responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405.
9. Guidotti, L., T. Ishikawa, M. Hobbs, B. Matzke, R. Schreiber, and F. Chisari. 1996. Intracellular inactivation of hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25.
10. Gallimore, A., H. Hengartner, and R. Zinkernagel. 1998. Hierarchies of antigen-specific cytotoxic T cell responses. Immunol. Rev. 164:29.
11. Van der Most, R., A. Sette, C. Oseroff, J. Alexander, K. Murali-Krishna, L. Lau, S. Southwood, J. Sidney, R. Chestnut, M. Matloubian, and R. Ahmed. 1996. Analysis of CTL responses to dominant and subdominant epitopes during acute and chronic LCMV infection. J. Immunol. 157:5543.
12. b-restricted subdominant CTL responses in LCMV-infected mice. Virology 240:158.
13. + T cell epitopes, viral load, and kinetics of primary antiviral CTL response. J. Immunol. 160:2923.
14. Sourdive, D., K. Murali-Krishna, J. Altman, A. Zajac, J. Whitmire, C. Pannetier, P. Kourilsky, B. Evavold, A. Sette, and R. Ahmed. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:71.
15. Murali-Krishna, K., J. Altman, M. Suresh, D. Sourdive, A. Zajac, J. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
16. + T cells during acute virus infection. Immunity 8:167.
17. Blattman, J., D. Sourdive, K. Murali-Krishna, R. Ahmed, and J. Altman. 2000. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J. Immunol. 165:6081.
18. Zajac, A., J. Blattman, K. Murali-Krishna, D. Sourdive, M. Suresh, J. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205.
19. Gallimore, A., T. Dumrese, H. Hengartner, R. Zinkernagel, and H. Hengartner. 1998. Protective immunity does not correlate with the hierarchy of virus-specific CTL responses to naturally processed peptides. J. Exp. Med. 187:1647.
20. Moskophidis, D., F. Lechner, H. Pircher, and R. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.
21. Oxenius, A., R. Zinkernagel, and H. Hengartner. 1998. Comparison of activation versus induction of unresponsiveness of virus-specific CD4 and CD8 T cells upon acute versus persistent virus infection. Immunity 9:449.
22. Pantaleo, G., J. Demarest, T. Schacker, M. Vaccarezza, O. Cohen, M. Daucher, C. Graziosi, S. Schnittmann, T. Quinn, and G. Shaw. 1997. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl. Acad. Sci. USA 94:254.
23. Klein, M., C. van Baalen, A. Holwerda, S. kerkhof Garde, R. Bende, I. Keet, J. eeftinck-Schattenkerk, A. Osterhaus, H. Schitemaker, and F. Miedema. 1995. Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.
24. Ogg, G., X. Jin, S. Bonhoeffer, P. Dunbar, M. Nowak, S. Monard, J. Segal, Y. Cao, S. Rowland-Jones, and Cerundolo, V. 1998. Quantitation of HIV-1-specific CTL and plasma load of viral RNA. Science 279:2103.
25. + T cell-deficient mice. J. Virol. 68:4700.
26. + CTL responses during chronic viral infection. J. Virol. 68:8056.
27. + T cells. J. Exp. Med. 184:863.
28. Bruns, M., T. Kratzberg, W. Zeller, and F. Lehmann-Grube. 1990. Mode of replication of lymphocytic choriomeningitis virus in persistently infected cultivated mouse L cells. Virology 177:615.
29. Pircher, H., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and R. Zinkernagel. 1990. Viral escape by selection of CTL-resistant variants in vivo. Nature 346:629.
30. + T cell tolerance. Immunity 18:713.
31. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1.
32. Buchmeier, M., R. Welsh, F. Dutko, and M. Oldstone. 1980. The virology and immunology of LCMV infection. Adv. Immunol. 30:275.
33. Pfau, C., J. Valenti, D. Pevear, and K. Hunt. 1982. Lymphocytic choriomeningitis killer cells are lethal only in weakly disseminated murine infections. J. Exp. Med. 156:79.
34. Cerundolo, V., A. Kelly, T. Elliott, J. Trowsdale, and A. Townsend. 1995. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immunol. 25:554.
35. Moss, B., and P. Earl. 1998. Expression of proteins in mammalian cells using vaccinia viral vectors. In Current Protocols in Molecular Biology. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. Wiley, New York, pp. 16.15.1-16.15.5.
36. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguelin, S. Ikehara, S. Muramatsu, and R. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/monocyte-colony stimulating factor. J. Exp. Med. 176:1693.
37. b complex to T cells. J. Immunol. 150:2724.
38. Schwarz, K., M. van den Broek, R. de Giuli, W. Seelentag, N. Shastri, and M. Groettrup. 2000. The use of LCMV-specific T-cell hybridomas for the quantitative analysis of MHC class I restricted antigen presentation. Immunol. Methods 237:199.
39. Altman, J., P. Moss, P. Goulder, D. Barouch, M. McHeyzer-Williams, J. Bell, A. McMichael, and M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
40. Gallimore, A., A. Glithero, A. Godkin, A. Tissot, A. Plückthun, T. Elliott, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of LCMV-specific T lymphocytes visualised using soluble tetrameric MHC class I-peptide complexes. J. Exp. Med. 187:1373.
41. Savage, P., J. Boniface, and M. Davis. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10:485.
42. Battegay, M., S. Cooper, A. Althage, J. Bänzinger, H. Hengartner, and R. Zinkernagel. 1991. Quantification of LCMV with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods. 33:191.
43. Ushcrwood, E., T. Hogg, and D. Woodland. 1999. Enumeration of antigen-presenting cells in mice infected with Sendai virus. J. Immunol. 162:3350.
44. Ou, R., S. Zhou, L. Huang, L., and D. Moskophidis. 2001. Critical role for α/β and γ interferons in persistence of LCMV by clonal exhaustion of cytotoxic T cells. J. Virol. 75:8407.
45. h presentation of gp33 revealed by comparative crystal structure analysis. Immunity 17:757.
46. Sevilla, N., S. Kunz, A. Holz, H. Lewicki, D. Homann, H. Yamada, K. Campbell, J. de la Torre, and M. Oldstone. 2000. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192:1249.
47. Oldstone, M., and M. Buchmeier. 1982. Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature 300:360.
48. Yewdell, J., L. Anton, and J. Bennink. 1996. Defective ribosomal products (DriPs): a major source of antigenic peptides for MHC class I molecules. J. Immunol. 157:1823.
49. Schubert, U., L. Anton, J. Gibbs, C. Norbury, J. Yewdell, and A. Bennink. 2000. Rapid degardation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770.
50. Reits, E., J. Vos, M. Gromme, M. and J. Neefjes. 2000. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404:774.
51. Khan, S., R. de Giuli, G. Schmidtke, M. Bruns, M. Buchmeier, M. van den Broek, and M. Groettrup. 2001. Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J. Immunol. 167:4801.
52. + T cell response to LCMV. J. Virol. 75:10663.
53. Geretti, A., and A. Osterhaus. 2001. Virus replication and evolution drive the kinetics and specificity of SIV-specific CTL. Immunol. Rev. 183:109.
54. Van Baalen, C., O. Pontesilli, R. Huisman, A. Geretti, M. Klein, F. de Wolf, F. Miedema, R. Gruters, and A. Osterhaus. 1997. Human immunodeficiency virus type 1 Rev and Tat specific CTL frequencies inversely correlate with rapid progression to AIDS. J. Gen. Virol. 78:1913.
55. Addo, M., M. Atfeld, E. Rosenberg, R. Elridge, M. Philips, K. Habeeb, A. Khatri, C. Brander, G. Robbins, G. Mazzara, et al. 2001. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by CTL derived from HIV-1-infected individuals. Proc. Natl. Acad. Sci. USA 98:1781.
56. Novitsky, V., N. Rybak, M. McLane, P. Gilbert, P. Chingwedere, I. Klein, S. Gaolekwe, S. Chang, T. Peter, I. Thior, et al. 2001. Identification of HIV-1C Gag-, Tat-, Rev-, and Nef-specific Elispot-based CTL responses for AIDS vaccine design. J. Virol. 75:9210.
57. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63.
58. + T cell expansions: evidence for impaired CTL effector function. Eur. J. Immunol. 31:677.
59. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30:2479.
60. Lechner, F., D. Wong, P. Dunbar, R. Chapman, R. Chung, P. Dobrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus, J. Exp. Med. 191:1499.
61. Sing, K., A. Ladhams, S. Arnold, H. Parmar, X. Chen, J. Cooper, L. Butterworth, K. Stuart, D. D'Arcy, and W. Cooksley. 2001. A longitudinal analysis of CTL precursor frequencies to the hepatitis B virus in chronically infected patients. J. Viral Hepatitis 8:19.
62. Erickson, A., Y. Kimura, S. S. Igarashi, J. Eichelberger, M. Houghton, J. Sidney, D. McKinney, A. Sette, A. Hughes, and C. Walker. 2001. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by CTL. Immunity 15:883.
63. Lee, P., C. Yee, P. Savage, L. Fong, D. Brockstedt, J. Weber, D. Johnson, S. Swetter, J. Thompson, P. Greenberg, M. Roederer, and M. Davis. 1999. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:677.